Συγγραφείς:
Belia, M.
Chatzidimitriou, C.
Rondogianni, P.
Petsa, P.
Efstathopoulou, M.
Konstantinou, E.
Arapaki, M.
Asimakopoulos, J.
Plata, E.
Konstantopoulos, K.
Angelopoulou, M.K.
Vassilakopoulos, T.P.
Λέξεις-κλειδιά:
bleomycin; brentuximab vedotin; busulfan; cisplatin; cytarabine; dacarbazine; doxorubicin; etoposide; gemcitabine; ifosfamide; melphalan; steroid; vinblastine; vinorelbine tartrate; brentuximab vedotin; immunological antineoplastic agent, adult; autologous stem cell transplantation; cancer combination chemotherapy; cancer radiotherapy; cancer regression; case report; clinical article; drug megadose; drug withdrawal; erythrocyte sedimentation rate; human; Letter; lymphadenopathy; male; maximum standardized uptake value; mediastinum mass; minimal residual disease; multiple cycle treatment; nodular sclerosis Hodgkin lymphoma; peripheral neuropathy; positron emission tomography-computed tomography; primary tumor; priority journal; salvage therapy; treatment response; autotransplantation; female; Hodgkin disease; multimodality cancer therapy; pathology; procedures; radiotherapy; salvage therapy; stem cell transplantation; treatment outcome, Adult; Antineoplastic Agents, Immunological; Brentuximab Vedotin; Combined Modality Therapy; Female; Hodgkin Disease; Humans; Male; Radiotherapy; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome
